KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) EBIT (2016 - 2025)

Incyte (INCY) has disclosed EBIT for 16 consecutive years, with $335.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIT rose 11.39% year-over-year to $335.9 million, compared with a TTM value of $1.5 billion through Dec 2025, up 2368.56%, and an annual FY2025 reading of $1.5 billion, up 2368.56% over the prior year.
  • EBIT was $335.9 million for Q4 2025 at Incyte, down from $443.5 million in the prior quarter.
  • Across five years, EBIT topped out at $530.3 million in Q2 2025 and bottomed at -$478.1 million in Q2 2024.
  • Average EBIT over 5 years is $168.1 million, with a median of $166.7 million recorded in 2023.
  • The sharpest move saw EBIT surged 4320.02% in 2021, then tumbled 346.74% in 2024.
  • Year by year, EBIT stood at $110.7 million in 2021, then crashed by 36.7% to $70.1 million in 2022, then skyrocketed by 167.17% to $187.3 million in 2023, then skyrocketed by 61.0% to $301.5 million in 2024, then grew by 11.39% to $335.9 million in 2025.
  • Business Quant data shows EBIT for INCY at $335.9 million in Q4 2025, $443.5 million in Q3 2025, and $530.3 million in Q2 2025.